clinical trial · NCT04750798
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias
Biosense Webster, Inc.·—·recruiting·n = 8,000
Arrhythmias, CardiacBWI Medical DeviceVaripulse CatheterDual Energy THERMOCOOL SMARTTOUCH SF Catheter
brief summary
The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc. (BWI) medical devices. Data generated from the study will be used to confirm safety and performance of BWI medical devices in the marketed phase and to expand the body of evidence on the use of these devices and techniques in treatment of cardiac arrhythmias.
started
Feb 22, 2021
primary completion
Dec 31, 2036
completion
Dec 31, 2037
last updated
Jun 5, 2026
official title
An Observational Post-marketing Study for Evaluation of Ongoing Safety and Effectiveness of Catheter Mapping and Ablation Using Commercially Approved BWI Medical Devices for the Treatment of Patients With Cardiac Arrhythmias
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol